Find a Supplier
ADD YOUR COMPANY
ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals
Contact Us Subscribe to Newsletter
Subscribe to Supplier

Subscribe to Supplier

.
ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals

ARTES Biotechnology GmbH News Releases

Find the latest News from ARTES Biotechnology GmbH

Page 2 of 4
ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals
ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals

Tuesday 2nd November 2021

By  ARTES Biotechnology… Learn More >
Cellumed and ARTES Sign Development and License Agreement
Cellumed and ARTES Sign Development and License Agreement

Thursday 14th October 2021

By  ARTES Biotechnology… Learn More >
“Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations
“Never again 2020: Let’s get vaccinated” – “Initiative against Corona” calls for vaccinations

Thursday 14th January 2021

By  ARTES Biotechnology… Learn More >
ARTES is convinced: defeating SARS COVID-19 will require different vaccines
ARTES is convinced: defeating SARS COVID-19 will require different vaccines

Friday 11th September 2020

By  ARTES Biotechnology… Learn More >
Worldwide, researchers work on a coronavirus vaccine
Worldwide, researchers work on a coronavirus vaccine

Tuesday 16th June 2020

By  ARTES Biotechnology… Learn More >
ARTES joins global CV-19 combat with VLP vaccine candidates
ARTES joins global CV-19 combat with VLP vaccine candidates

Monday 27th April 2020

By  ARTES Biotechnology… Learn More >
France renews CIR tax credits for ARTES R&D services
France renews CIR tax credits for ARTES R&D services

Thursday 2nd April 2020

By  ARTES Biotechnology… Learn More >
ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris
ARTES presenting opportunities for vaccine development at BIO-Europe Spring in Paris

Monday 9th March 2020

By  ARTES Biotechnology… Learn More >
Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute
Data on production and immunogenicity of malaria transmission-blocking vaccine candidates published by ARTES and Burnet Institute

Friday 13th September 2019

By  ARTES Biotechnology… Learn More >
ARTES presenting new development offer at BIOEurope Spring in Vienna
ARTES presenting new development offer at BIOEurope Spring in Vienna

Tuesday 12th March 2019

By  ARTES Biotechnology… Learn More >
ARTES adds SplitCore technology to vaccine development portfolio
ARTES adds SplitCore technology to vaccine development portfolio

Monday 7th January 2019

By  ARTES Biotechnology… Learn More >
ARTES and Minapharm join forces to package biopharma solutions
ARTES and Minapharm join forces to package biopharma solutions

Monday 10th September 2018

By  ARTES Biotechnology… Learn More >
Page 2 of 4
Full Supplier Profile